Searched for
ZYDUS LIFESCIENCES REVENUE GROWTH
Espire Hospitality posts revenue of Rs 141 crore for FY26, PAT at Rs 8 croreEspire Hospitality has achieved a landmark financial year 2026, reporting Rs 141 crore in revenue, a 17% increase, and Rs 8 crore in profit...- Organised dairy sector may clock 13-15% revenue growth this fiscal: CrisilThe organized dairy industry in India is on track to achieve remarkable revenue growth, anticipated at 13-15% this fiscal year. Increased d...
- Market Trading Guide: Finolex Cables among 2 stock recommendations for TuesdayDomestic equities closed higher on positive Asian cues, falling crude oil prices and hopes of an India-US trade deal. Analysts recommend bu...
- PayU India posts first full-year operating profit in FY26; revenue rises 13%During the second half of FY26, PayU India also exited certain "negative margin portfolios", impacting its sequential revenue growth. In th...
- AI chip rally faces reality check, but bubble fears may be overdone: Adrian MowatSouth Korean chip stocks are experiencing a temporary dip, not an AI bubble burst, according to EM-Equity Strategist Adrian Mowat. He attri...
- Auto ancillary sector revenue grew 12.5% in FY26 on volume gains and improved product mix: ReportIndian auto ancillaries witnessed robust revenue growth of 12.5% in FY26, driven by strong volumes and a better product mix. While EBITDA a...
- Persistent's Nagarro deal could be a near-term pain for long-term gainPersistent Systems is acquiring Nagarro SE for $1.3 billion, aiming for European expansion and reduced US market reliance. While strategica...
- Man receives 60% salary hike days before he exits the company, is not happy: 'In my mind...'A product marketing manager's resignation took an unexpected turn when his company offered a significant salary hike just days before his d...
- ITC's packaged foods business crosses $2 billion in revenueITC's packaged food business soared past $2 billion in FY26, with overall FMCG consumer spending reaching Rs 37,000 crore. This growth was ...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Federal Bank among 6 stocks that hit 52-week highs, rally up to 15% in a monthSix BSE200 stocks, including Federal Bank and Bharat Forge, hit fresh 52-week highs amid a strong market rally, reflecting bullish momentum...
- Largecaps lead profit growth, mid & smallcaps outshine in revenue momentum in Q4Large companies saw stronger net profit growth for the March 2026 quarter, driven by one-off gains, despite slower revenue expansion and wi...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?Investors have a final opportunity to tender shares in buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems and ...
Load More
